OBJECTIVES: The purpose of this study was to test the hypothesis that the late Na current blocker ranolazine suppresses re-entrant and multifocal ventricular fibrillation (VF). BACKGROUND: VF can be caused by either re-entrant or focal mechanism. METHODS: Simultaneous voltage and intracellular Ca(+)² optical mapping of the left ventricular epicardial surface along with microelectrode recordings was performed in 24 isolated-perfused aged rat hearts. Re-entrant VF was induced by rapid pacing and multifocal VF by exposure to oxidative stress with 0.1 mM hydrogen peroxide (H₂O₂). RESULTS: Rapid pacing induced sustained VF in 7 of 8 aged rat hearts, characterized by 2 to 4 broad propagating wavefronts. Ranolazine significantly (p < 0.05) reduced the maximum slope of action potential duration restitution curve and converted sustained to nonsustained VF lasting 24 ± 8 s in all 7 hearts. Exposure to H₂O₂ initiated early afterdepolarization (EAD)-mediated triggered activity that led to sustained VF in 8 out of 8 aged hearts. VF was characterized by multiple foci, appearing at an average of 6.8 ± 3.2 every 100 ms, which remained confined to a small area averaging 2.8 ± 0.85 mm² and became extinct after a mean of 43 ± 16 ms. Ranolazine prevented (when given before H₂O₂) and suppressed H₂O₂-mediated EADs by reducing the number of foci, causing VF to terminate in 8 out of 8 hearts. Simulations in 2-dimensional tissue with EAD-mediated multifocal VF showed progressive reduction in the number of foci and VF termination by blocking the late Na current. CONCLUSIONS: Late Na current blockade with ranolazine is effective at suppressing both pacing-induced re-entrant VF and EAD-mediated multifocal VF. Copyright Â
OBJECTIVES: The purpose of this study was to test the hypothesis that the late Na current blocker ranolazine suppresses re-entrant and multifocal ventricular fibrillation (VF). BACKGROUND:VF can be caused by either re-entrant or focal mechanism. METHODS: Simultaneous voltage and intracellular Ca(+)² optical mapping of the left ventricular epicardial surface along with microelectrode recordings was performed in 24 isolated-perfused aged rat hearts. Re-entrant VF was induced by rapid pacing and multifocal VF by exposure to oxidative stress with 0.1 mM hydrogen peroxide (H₂O₂). RESULTS: Rapid pacing induced sustained VF in 7 of 8 aged rat hearts, characterized by 2 to 4 broad propagating wavefronts. Ranolazine significantly (p < 0.05) reduced the maximum slope of action potential duration restitution curve and converted sustained to nonsustained VF lasting 24 ± 8 s in all 7 hearts. Exposure to H₂O₂ initiated early afterdepolarization (EAD)-mediated triggered activity that led to sustained VF in 8 out of 8 aged hearts. VF was characterized by multiple foci, appearing at an average of 6.8 ± 3.2 every 100 ms, which remained confined to a small area averaging 2.8 ± 0.85 mm² and became extinct after a mean of 43 ± 16 ms. Ranolazine prevented (when given before H₂O₂) and suppressed H₂O₂-mediated EADs by reducing the number of foci, causing VF to terminate in 8 out of 8 hearts. Simulations in 2-dimensional tissue with EAD-mediated multifocal VF showed progressive reduction in the number of foci and VF termination by blocking the late Na current. CONCLUSIONS: Late Na current blockade with ranolazine is effective at suppressing both pacing-induced re-entrant VF and EAD-mediated multifocal VF. Copyright Â
Authors: Aman Mahajan; Daisuke Sato; Yohannes Shiferaw; Ali Baher; Lai-Hua Xie; Robert Peralta; Riccardo Olcese; Alan Garfinkel; Zhilin Qu; James N Weiss Journal: Biophys J Date: 2008-01-15 Impact factor: 4.033
Authors: Martyn P Nash; Ayman Mourad; Richard H Clayton; Peter M Sutton; Chris P Bradley; Martin Hayward; David J Paterson; Peter Taggart Journal: Circulation Date: 2006-07-31 Impact factor: 29.690
Authors: Yejia Song; John C Shryock; Stefan Wagner; Lars S Maier; Luiz Belardinelli Journal: J Pharmacol Exp Ther Date: 2006-03-24 Impact factor: 4.030
Authors: A Garfinkel; P S Chen; D O Walter; H S Karagueuzian; B Kogan; S J Evans; M Karpoukhin; C Hwang; T Uchida; M Gotoh; O Nwasokwa; P Sager; J N Weiss Journal: J Clin Invest Date: 1997-01-15 Impact factor: 14.808
Authors: Arvinder K Dhalla; Wei-Qun Wang; Joan Dow; John C Shryock; Luiz Belardinelli; Anil Bhandari; Robert A Kloner Journal: Am J Physiol Heart Circ Physiol Date: 2009-09-18 Impact factor: 4.733
Authors: Kapil Kumar; Bruce D Nearing; Carlo R Bartoli; Kevin F Kwaku; Luiz Belardinelli; Richard L Verrier Journal: J Cardiovasc Electrophysiol Date: 2008-05-09
Authors: Zhilin Qu; Lai-Hua Xie; Riccardo Olcese; Hrayr S Karagueuzian; Peng-Sheng Chen; Alan Garfinkel; James N Weiss Journal: Cardiovasc Res Date: 2013-04-25 Impact factor: 10.787
Authors: Byron N Roberts; Pei-Chi Yang; Steven B Behrens; Jonathan D Moreno; Colleen E Clancy Journal: Am J Physiol Heart Circ Physiol Date: 2012-08-10 Impact factor: 4.733